1Mannello F. Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon? [J]. Recent PatAnticancer Drug Discov, 2006, 1(1): 91-103.
2Leeman MF, Curran S, Murray GI. The structure, regulation, and function of human matrix metalloproteinase-13 [J]. Crit Rev Biochem Mol Biol, 2002, 37(3): 149-166.
3Visse R, Nagase H. Matrix metalloproteinases and tissue in- hibitors of metalloproteinases:structure, function, and bio- chemistry[J]. Circ Res, 2003, 92(8): 827-839.
4Kanemoto M, Hukuda S, Komiya Y, et al. Immunohisto- chemical study of matrix metalloproteinase-3 and tissue in- hibitor of metalloproteinase-1 human intervertebral discs[J]. Spine (Phila Pa 1976), 1996, 21(1): 1-8.
5Neuhold LA, Killar L, Zhao W, et al. Postnatal expression in hyaline cartilage of constitutively active human eollage- nase-3 (MMP-13) induces osteoarthritis in mice [J]. J Clin Invest, 2001, 107(1): 35-44.
6Monfort J, Tardif G, Reboul P, et al. Identification of a new biglycan cleavage site [J]. Arthritis Res Ther, 2006, 8 (1): R26.
7Sadick H, Herberger A, Riedel K, et al. TGF-hetal anti- sense therapy modulates expression of matrix metallopro- teinases in keloid-derived fibroblasts [J]. Int J Mol Med, 2008, 22(1): 55-60.
